1-DAY ACUVUE® MOIST

1-Day ACUVUE® MOIST Contact Lenses
1-DAY ACUVUE® MOIST contact lenses are made for patients who are prone to dry eyes and sensitivity. 1-DAY ACUVUE® MOIST contact lenses with LACREON® Technology has locked-in wetting agent PVP which provides long lasting cushion of moisture for 20 hours or more.1
1-Day ACUVUE® MOIST Contact Lenses
1-DAY ACUVUE® MOIST contact lenses are made for patients who are prone to dry eyes and sensitivity. 1-DAY ACUVUE® MOIST contact lenses with LACREON® Technology has locked-in wetting agent PVP which provides long lasting cushion of moisture for 20 hours or more.1

Benefits to share with your patients

Convenience

The freedom and convenience of a fresh, new lens every day

Unbeaten in comfort*

In 11 clinical studies posted on ClinicalTrials.gov, 1-DAY ACUVUE® MOIST brand spherical contact lenses have never been beaten in comfort when compared to other hydrogel daily disposable contact lenses.*


Class 2 UV-blocking3#^

MOIST brand contact lenses block 99% of UVB and 85% of UVA.3#^

30-day or 90-day pack

About 1 or 3 months' worth of contact lenses in one box.

Lens specifications

TitleDescription

Lens material

Etafilcon A

Technology

LACREON® Technology

Oxygen transmissibility (Dk/t)

25.5 x 10-9 (-3.00D lens)

Water Content

41%

Oxygen % available to central cornea

88%

Class 2 UV blocking3#^

99% UVB, 85% UVA

Center thickness at -3.00D (mm)

0.084mm

Base Curve

8.5mm, 9.0mm

Diameter

14.2mm

Power Range

-0.50D to -6.00D (0.25D steps)

-6.50D to -12.00D (0.50D steps)

+0.50D to +6.00D (0.25D steps)

Visibility features

Visibility tint, ‘123’ inversion indicator

Replacement Schedule

Single use: 1-day replacement

Pack size

Available in 30 and 90 day pack for daily wear

A closer look at what sets these apart

More key benefits

  • LACREON® Technology, with the locked-in wetting agent PVP, provides a long-lasting cushion of moisture for 20 hours or more1
  • Etafilcon A helps keep the eye environment in its natural state, which might otherwise lead to irritation**
  • Unique EYE-INSPIRED Invisible Edge design for comfort2

Related Products

Packing solution contains boric acid and disodium tetraborate (sodium borate) to control the pH of the solution.

*ClinicalTrials.gov is a website maintained by the NIH. The 11 clinical studies evaluated subjective comfort as a primary or secondary endpoint for 1-DAY ACUVUE® MOIST brand family (spherical ONLY) contact lenses vs. competitors’ products. Review conducted as of April 30, 2023.

#Helps protect against transmission of harmful UV radiation to the cornea and into the eye.

**All ACUVUE® contact lenses have Class 1 or Class 2 UV-blocking to help provide protection against transmission of harmful UV radiation to the cornea and into the eye. UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area.

^Based on in-vitro data, clinical studies have not been done directly linking differences in lysozyme profile with specific clinical benefits.

1. JJV Data on File 2021. Dual Action Technology and “Cushion of Moisture” Description for 1-DAY ACUVUE® MOIST Brand Family of Contact Lenses.

2. JJV Data on File 2020. ACUVUE® Brand - EYE-INSPIRED Innovations.

3. JJV Data on File 2022. Material Properties: 1-DAY ACUVUE® MOIST, 1-DAY ACUVUE® TruEye®, ACUVUE® OASYS 1-Day with HydraLuxe® Technology and ACUVUE® OASYS MAX 1-Day with TearStable Technology Brand Contact Lenses.

4. Heynen M, Omali NB, Fadli Z, et al. Selectivity and localization of lysozyme uptake in contemporary hydrogel contact lens materials. J Biomater. Sci. Polym. Ed. 2017;28(13):1351-1364. doi:10.1080/09205063.2017.1327751.

Important Safty Information: ACUVUE® Contact Lenses are indicated for vision correction. As with any contact lenses, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Contact lenses should not be used in case of eye infections or any other eye conditions, or in case of a systemic disease that may affect the eye. For detailed product information, including contraindications, precautions and adverse reactions, please consult the Instructions for Use available on the Johnson & Johnson website https://www.e-ifu.com/.

2024PP15399
Johnson & Johnson
Important Safety Information: ACUVUE® Contact Lenses are indicated for vision correction. As with any contact lenses, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Contact lenses should not be used in case of eye infections or any other eye conditions, or in case of a systemic disease that may affect the eye. For detailed product information, including contraindications, precautions and adverse reactions, please consult the lnstructions for Use available on Johnson & Johnson website https://www.e-ifu.com/. Important Safety Information: ACUVUE Revitalens Multi-Purpose Disinfecting Solution (MPDS) is indicated for the care of soft (hydrophilic) contact lenses, including silicone hydrogel lenses. For detailed product information, including warnings and precautions, please consult the Instructions for Use. Failure to do so may result in serious eye infection or injury.  © Janssen-Cilag AS. 2025. All rights reserved. This site is published by Janssen-Cilag AS, which is solely responsible for its content. It is intended for use by Eye Care Professionals in Norway. ACUVUE®, 1-DAY ACUVUE® MOIST, 1-DAY ACUVUE® MOIST for ASTIGMATISM, 1-DAY ACUVUE® MOIST MULTIFOCAL, ACUVUE® OASYS, ACUVUE® OASYS MULTIFOCAL, ACUVUE® OASYS for ASTIGMATISM, ACUVUE® OASYS 1-Day for ASTIGMATISM, ACUVUE® OASYS 1-Day, ACUVUE® OASYS MAX 1-Day, ACUVUE® OASYS MAX 1-Day MULTIFOCAL, ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM, ACUVUE® OASYS MAX 1-Day for ASTIGMATISM, ACUVUE RevitaLens, TearStable, OptiBlue, LACREON®, EYE-INSPIRED and HydraLuxe® are trademarks of Johnson & Johnson. Third-party trademarks used herein are trademarks of their respective owners. Last Update: Last Update: July 2, 2025.